Journal of Drugs in Dermatology - Phase III trials for the treatment of hereditary angioedema
Journal of Drugs in Dermatology - Phase III trials for the treatment of hereditary angioedema
November 1, 2006 -- Kos Pharmaceuticals, Inc, recently announced positive preliminary results from 2 Phase III trials of Icatibant for the subcutaneous treatment of...
Click Here to read the entire article...
more angioedema articles...
>> |
|
|
What Are The Main Causes Of Angioedema?
There are four main causes of Angioedema. These include: ACE (angiotensin-converting enzyme) inhibitor, allergic reactions, Hereditary or acquired C1 inhibitor deficiency and idiopathic category.
|
|